J.ophthalmol.(Ukraine).2019;6:70-75.
http://doi.org/10.31288/oftalmolzh201967075
Received: 17 October 2019; Published on-line: 08 January 2020
A case report of uveitis with ocular hypertension
N. V. Konovalova, Dr. Sc. (Med.); V. V. Savko, Dr. Sc. (Med.); N. I. Khramenko, Cand. Sc. (Med.); O. V. Guzun, Cand. Sc. (Med.); S. B. Slobodianyk, Cand. Sc. (Med.); Iu. A. Zhuravok, Cand. Sc. (Med.); V. V. Savko, Jr., Cand. Sc. (Med.)
SI "The Filatov Institute of Eye Diseases and Tissue Therapy of the National Academy of Medical Sciences of Ukraine"; Odesa (Ukraine)
E-mail: kvnkonovalova@gmail.com
TO CITE THIS ARTICLE: Konovalova NV, Savko VV, Khramenko NI, Guzun OV, Slobodianyk SB, Zhuravok IuA, Savko VV, Jr. A case report of uveitis with ocular hypertension. J.ophthalmol.(Ukraine).2019;6:70-75. http://doi.org/10.31288/oftalmolzh201967075
Based on a clinical case, we analyzed the characteristics of diagnosis, course, and treatment of uveitis in the presence of ocular hypertension.
Keywords: uveitis, ocular hypertension, prostaglandin analogues
References:
1.Arbenyeva NS, Chekhova TA, Bratko GV, Chernakh VV. [Comparative analysis of diseases incidence in patients with uveitis]. [The Annual All-Russian Scientific Practical Conference of Young Scientists «Current Problems of Ophthalmology». Abstract book]. M.: Oftalmologiia; 2012: 28-29. In Russian
2.Drozdova EA. [The classification and epidemiology of uveitis]. RMZh. Klinicheskaia Oftalmologiia; 2016;3:155-9. In Russian.
3.Panova IE, Drozdova EA. [Uveitis: Guidance for practitioners]. M.: Meditsinskoie informatsionnoie agenstvo; 2014. 144p. In Russian.
4.Аnamori A, Naka M, Fukuda M et al. Latanoprost protects rat retinal ganglion cells from apoptosis in vitro and in vivo. Exp. Eye Res. 2009;88(3):535–41
5.Asrani S, Moore DB, Jaffe GJ. Paradoxical changes of retinal nerve fiber layer thickness in uveitic glaucoma. JAMA Ophthalmology. 2014; 132(7): 877–80. doi: 10.1001/jamaophthalmol.2014.954.
6.Boltz A, Schmidl D, Weigert G et al. Effect of latanoprost on choroidal blood flow regulation in healthy subjects.Invest. Ophthalmol. Vis. Sci. 2011;52(7):4410–5.
7.Horsley MB, Chen TC. The use of prostaglandin analogs in the uveitis patient. Seminars in Ophthalmology. 2011;26(4-5):285–9.
8.Kurashima H, Watabe H, Sato N et al. Effects of prostaglandin F(2?) analogues on endothelin-1-induced impairment of rabbit ocular blood flow: comparison among tafluprost, travoprost, and latanoprost. Exp. Eye Res. 2010; 91(6):853–9.
9.Markomichelakis NN, Kostakou A, Halkiadakis I, Chalkidou S, Papakonstantinou D, Georgopoulos G. Efficacy and safety of latanoprost in eyes with uveitis glaucoma. Graefe's Arch for Clin and Exp Ophthalmol. 2009;247(6):775–80.
10.Nakanishi Y, Nakamura M, Mukuno H et al. Latanoprost rescues retinal neuro-glial cells from apoptosis by inhibiting caspase-3, which is mediated by p44/p42 mutagen-activated protein kinas. Exp. Eye Res. 2006;83(5):1108–17.
11.Takeuchi M, Kanda T, Taguchi M et al. Evaluation of Efficacy and Safety of Latanoprost/Timolol versus Travoprost/Timolol Fixed Combinations for Ocular Hypertension Associated with Uveitis. Ocul Immunol Inflamm. 2017; Feb 25 (1):105-10.